Xeris Biopharma Holdings
XERS
XERS
67 hedge funds and large institutions have $45.8M invested in Xeris Biopharma Holdings in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
2.8% less ownership
Funds ownership: 65.31% → 62.51% (-2.8%)
64% less capital invested
Capital invested by funds: $128M → $45.8M (-$82.2M)
Holders
67
Holding in Top 10
–
Calls
$22K
Puts
$23K
Top Buyers
| 1 | +$6.3M | |
| 2 | +$1.66M | |
| 3 | +$1.05M | |
| 4 |
AGM
Alpine Global Management
New York
|
+$985K |
| 5 |
D.E. Shaw & Co
New York
|
+$940K |
Top Sellers
| 1 | -$4.17M | |
| 2 | -$4.16M | |
| 3 | -$1.21M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$331K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$282K |